Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Hematology ; 27(1): 1056-1061, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36112003

ABSTRACT

BACKGROUND: The CYP2C19 gene is highly polymorphic, and CYP2C19 is involved in the broad interindividual variability of the clinical efficacy of certain clinical medications, such as clopidogrel. However, data on the CYP2C19 genotype in the Chinese population of the Foshan area of Guangdong Province are scarce. The purpose of this study was to determine CYP2C19 genetic polymorphisms in patients in the Foshan area and to compare the CYP2C19 genotype frequencies in different populations to determine the allele distribution pattern to identify the most appropriate prescription. METHODS: The CYP2C19 gene was detected in 1231 patients on a gene chip platform, and the genotype frequencies of CYP2C19 in Foshan populations from different populations were compared. RESULTS: The frequencies of CYP2C19*1, *2 and *3 in the Foshan population were 63.89%, 30.46% and 5.65%, respectively. For the three metabolic types, the frequency associated with the rapid metabolism type (*1/*1) was 41.51 [95% confidence interval (CI) 40.11 to 42.91%]; that for the intermediate metabolism type (*1/*2, *1/*3) was 44.76% (95% CI 43.34 to 46.18) and that for the slow metabolism type (*2/*2, *2/*3, *3/*3) was 13.73% (95% CI 12.75 to 14.71%). In the Foshan population, the frequencies of the CYP2C19 *2 and *3 alleles were similar to those previously reported for Chinese and other Asian populations. CONCLUSION: Our study is a report on the genetic basis of CYP2C19 polymorphism in the Foshan population. Our results will potentially contribute to the improvement of pharmacotherapy effectiveness by providing personalized medicine for the Foshan population.


Subject(s)
Clopidogrel , Cytochrome P-450 CYP2C19 , Aryl Hydrocarbon Hydroxylases/genetics , Aryl Hydrocarbon Hydroxylases/metabolism , China , Clopidogrel/pharmacology , Clopidogrel/therapeutic use , Cytochrome P-450 CYP2C19/genetics , Gene Frequency , Humans , Polymorphism, Genetic
2.
Zhonghua Wai Ke Za Zhi ; 48(16): 1252-5, 2010 Aug 15.
Article in Chinese | MEDLINE | ID: mdl-21055217

ABSTRACT

OBJECTIVE: To comprehend the anatomic characteristics and correlations between the accessory nerve and the phrenic nerve in the adult corpses. METHODS: The bilateral accessory nerves, phrenic nerves, and their branches of 20 adult corpses (38 sides) were underwent exposure. The morphologic data of the accessory nerves and the phrenic nerves above clavicle were measured. In addition, the minimal and maximal distances from several points on the accessory nerve to the full length of the phrenic nerve above clavicle were measured. Then, the number of motor nerve fibers on different locations of the nerves utilizing the method of immunohistochemistry were counted and compared. RESULT: The accessory nerves after sending out the sternocleido-mastoid muscular branches were similar in the morphologic data with the phrenic nerves. Meanwhile, the accessory nerve had a coiled appearance within this geometrical area. The possibly minimal distance between the accessory nerve and phrenic nerve was (3.19 ± 1.23) cm, and the possibly maximal distance between the starting point of accessory nerve and the end of the phrenic nerve above clavicle was (8.71 ± 0.75) cm. CONCLUSIONS: The accessory nerve and the phrenic nerve are similar in the anatomic evidences and the number of motor nerve fibers. And the length of accessory nerve is sufficiently long to connect with phrenic nerve as needed. It is possible to suture them without strain directly.


Subject(s)
Accessory Nerve/anatomy & histology , Phrenic Nerve/anatomy & histology , Accessory Nerve/surgery , Adult , Female , Humans , Male , Nerve Transfer , Phrenic Nerve/surgery
3.
Zhongguo Zhong Yao Za Zhi ; 31(14): 1157-9, 2006 Jul.
Article in Chinese | MEDLINE | ID: mdl-17048583

ABSTRACT

OBJECTIVE: To study the chemical components of the essential oil of the Semen Sinapis with the different processing methods. METHOD: The essential oils of the crude Semen Sinapis and the roasted Semen Sinapis were extracted by steam distillation. The chemical components were analyzed by means of GC-MS-DS. The relative content of each component was calculated by area normalization. RESULT: The main chemical components of the essential oil of the crude Semen Sinapis and the roasted Semen Sinapis were similar. The main chemical components were allyl isothiocyanate and 4-isothio-cyanato-1-butene. The chemical components of the essential oil of the crude Semen Sinapis were more than that of the roasted Semen Sinapis. CONCLUSION: The effect of different processing methods on the chemical components of the essential oil of Semen Sinapis was significant. Certain chemical components such as isothiocyanato-containing substances, were found in the crude Semen Sinapis.


Subject(s)
Isothiocyanates/analysis , Oils, Volatile/chemistry , Plants, Medicinal/chemistry , Sinapis/chemistry , Technology, Pharmaceutical/methods , Hot Temperature , Oils, Volatile/isolation & purification , Plant Oils/chemistry , Plant Oils/isolation & purification , Seeds/chemistry
4.
J Alzheimers Dis ; 7(2): 139-48; discussion 173-80, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15851852

ABSTRACT

Abnormal production and accumulation of amyloid-beta peptide (Abeta) plays a major role in the pathogenesis of Alzheimer's disease (AD). beta-secretase (BACE1) is responsible for the cleavage at thebeta-site in amyloid beta protein precursor (AbetaPP/APP) to generate the N-terminus of Abeta. Here we report the stepwise identification and characterization of a novel APP-beta-site mutant, "NFEV" (APP_NFEV) in vitro and in cells. In vitro, the APP_NFEV exhibits 100-fold enhanced cleavage rate relative to the "wild-type" substrate (APPwt) and 10-fold increase relative to the Swedish-type mutation variant (APPsw). In cells, it was preferably cleaved among 24 APP beta-site mutations tested. More importantly, the APP_NFEV mutant failed to generate any detectable Abeta peptides in BACE1-KO mouse fibroblast cells. The production of Abeta peptides was restored by co-transfecting human BACE1, demonstrating that BACE1 is the only enzyme responsible for the processing of APP_NFEV in these cells. Analysis of APP_NFEV cleavage products secreted in the media revealed that in cells BACE1 cleaves APP_NFEV at the position between NF and EV, identical to that observed in vitro. A BACE inhibitor blocked the processing of the APP_NFEV beta-site in vitro and in cells. Our data indicates that the "NFEV" mutant is not only an enhanced substrate for BACE1 in vitro, but also a specific substrate for BACE1 in cells.


Subject(s)
Amyloid beta-Peptides , Amyloid beta-Protein Precursor/genetics , Aspartic Acid Endopeptidases/genetics , Peptide Fragments , Point Mutation/genetics , Alzheimer Disease/enzymology , Alzheimer Disease/genetics , Alzheimer Disease/immunology , Amyloid Precursor Protein Secretases , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/biosynthesis , Amyloid beta-Peptides/genetics , Animals , Antibodies, Monoclonal/immunology , Aspartic Acid Endopeptidases/metabolism , Disease Models, Animal , Endopeptidases , Enzyme Activation/physiology , Fibroblasts/metabolism , Gene Expression Regulation, Enzymologic , In Vitro Techniques , Mice , Molecular Sequence Data , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/biosynthesis , Peptide Fragments/genetics , Substrate Specificity , Transfection
5.
J Biol Chem ; 278(23): 21286-94, 2003 Jun 06.
Article in English | MEDLINE | ID: mdl-12665519

ABSTRACT

The amyloid beta peptides (Abeta) are the major components of the senile plaques characteristic of Alzheimer's disease. Abeta peptides are generated from the cleavage of amyloid precursor protein (APP) by beta- and gamma-secretases. Beta-secretase (BACE), a type-I transmembrane aspartyl protease, cleaves APP first to generate a 99-amino acid membrane-associated fragment (CT99) containing the N terminus of Abeta peptides. Gamma-secretase, a multi-protein complex, then cleaves within the transmembrane region of CT99 to generate the C termini of Abeta peptides. The production of Abeta peptides is, therefore, dependent on the activities of both BACE and gamma-secretase. The cleavage of APP by BACE is believed to be a prerequisite for gamma-secretase-mediated processing. In the present study, we provide evidence both in vitro and in cells that BACE-mediated cleavage between amino acid residues 34 and 35 (Abeta-34 site) in the Abeta region is dependent on gamma-secretase activity. In vitro, the Abeta-34 site is processed specifically by BACE1 and BACE2, but not by cathepsin D, a closely related aspartyl protease. Moreover, the cleavage of the Abeta-34 site by BACE1 or BACE2 occurred only when Abeta 1- 40 peptide, a gamma-secretase cleavage product, was used as substrate, not the non-cleaved CT99. In cells, overexpression of BACE1 or BACE2 dramatically increased the production of the Abeta 1-34 species. More importantly, the cellular production of Abeta 1-34 species induced by overexpression of BACE1 or BACE2 was blocked by a number of known gamma-secretase inhibitors in a concentration-dependent manner. These gamma-secretase inhibitors had no effect on enzymatic activity of BACE1 or BACE2 in vitro. Our data thus suggest that gamma-secretase cleavage of CT99 is a prerequisite for BACE-mediated processing at Abeta-34 site. Therefore, BACE and gamma-secretase activity can be mutually dependent.


Subject(s)
Amyloid beta-Peptides/metabolism , Aspartic Acid Endopeptidases/metabolism , Endopeptidases/metabolism , Amino Acid Sequence , Amyloid Precursor Protein Secretases , Aspartic Acid Endopeptidases/chemistry , Aspartic Acid Endopeptidases/genetics , Cathepsin D/metabolism , Cell Membrane/enzymology , Cells, Cultured , Cytoplasm/enzymology , Enzyme Activation , Gene Expression Regulation, Enzymologic , Humans , In Vitro Techniques , Kidney/cytology , Molecular Sequence Data , Peptide Fragments/metabolism , Protein Structure, Tertiary , Substrate Specificity
6.
Zhongguo Zhong Yao Za Zhi ; 28(7): 643-6, 2003 Jul.
Article in Chinese | MEDLINE | ID: mdl-15139111

ABSTRACT

OBJECTIVE: To study the active components and their functionary mechanism of the extract of Brassica alba seeds, which inhibits experimental mice prostatic hyperplasia. METHOD: Prostatic hyperplasia of castrated male mice induced by testosterone propionate, the penetrability of capillary vessel of mice skin induced by histamine and the endermic flesh bud of rat induced by filter paper were used as experimental models. Sinalbin and beta-sitosterol separated from seeds of Brassica alba were used to test the activities. RESULT: Sinalbin and beta-sitosterol(16.0 mg.kg-1.d-1 and 8.0 mg.kg-1.d-1) could significantly inhibit mice prostatic hyperplasia induced by testosterone propionate and activity of serum acid phosphatase(P < 0.01 or P < 0.05), Sinalbin(16.0 mg.kg-1.d-1)could significantly inhibit the hyperplasia of endermic flesh bud in rat induced by filter paper(P < 0.05), beta-sitosterol(16.0 mg.kg-1.d-1 and 8.0 mg.kg-1.d-1) could significantly decrease the penetrability of capillary vessel of mice skin induced by histamine. CONCLUSION: Sinalbin and beta-sitosterol have anti-androgen and anti-inflammation activities.


Subject(s)
Androgen Antagonists/pharmacology , Choline/analogs & derivatives , Choline/pharmacology , Mustard Plant , Prostatic Hyperplasia , Sitosterols/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Capillary Permeability/drug effects , Choline/isolation & purification , Female , Male , Mice , Mustard Plant/chemistry , Orchiectomy , Plants, Medicinal/chemistry , Prostatic Hyperplasia/blood , Prostatic Hyperplasia/chemically induced , Prostatic Hyperplasia/physiopathology , Rats , Rats, Sprague-Dawley , Seeds/chemistry , Sitosterols/isolation & purification , Testosterone Propionate
7.
Zhongguo Zhong Yao Za Zhi ; 27(10): 766-8, 2002 Oct.
Article in Chinese | MEDLINE | ID: mdl-12776559

ABSTRACT

OBJECTIVE: To study the effective fraction of the extract of seeds of Brassica alba, which inhibits experimental mice prostatic hyperplasia. METHOD: An experimental model of prostatic hyperplasia of castrated male mice induced by testosterone propionate was made. Fractions I, II and III were prepared by extracting the seeds of Brassica alba successively with ether, ethanol and water under reflux. Total extract was prepared by extracting the seeds of Brassica alba with 60% ethanol under reflux. The total extract and the three fractions were used to test the activities. RESULT: Total extract, fractions I and II could not only significantly inhibit mice prostatic hyperplasia induced by testosterone propionate and activity of serum acid phosphatase, but also decrease wet weight of preputial glands, while fraction III is inactive. CONCLUSION: Extract from seeds of Brassica alba can significantly inhibit mice prostatic hyperplasia induced by exterior hormone, possessing an activity of anti-androgen. Fractions I and II show an equivalent activity of total extract, which indicate that these fractions contain active components of seeds of Brassica alba which can inhibit prostatic hyperplasia.


Subject(s)
Acid Phosphatase/blood , Brassica/chemistry , Drugs, Chinese Herbal/pharmacology , Plants, Medicinal/chemistry , Prostate/drug effects , Prostatic Hyperplasia/pathology , Animals , Drugs, Chinese Herbal/isolation & purification , Male , Mice , Orchiectomy , Organ Size/drug effects , Prostatic Hyperplasia/blood , Prostatic Hyperplasia/chemically induced , Seeds/chemistry , Testosterone
SELECTION OF CITATIONS
SEARCH DETAIL
...